期刊文献+

阿哌沙班-烟酸一水合物共晶的制备、表征及性质研究

Preparation,characterization and properties of apixaban-nicotinic acid monohydrate co-crystal
原文传递
导出
摘要 目的制备阿哌沙班-烟酸一水合物共晶(物质的量之比1∶1∶1)。方法采用溶媒结晶法,以阿哌沙班和烟酸为原料、三氟乙醇-乙酸乙酯为结晶溶剂体系,室温条件下用含水0.5%(体积分数)的三氟乙醇搅拌3 h溶解澄清,之后加入乙酸乙酯析晶2 h,过滤,干燥,得到目标产物。结果与结论应用^(1)H-NMR分析、元素分析、含水量分析、X-射线粉末衍射(XRPD)、差示扫描量热分析(DSC)、热重分析(TGA)、红外光谱分析等对本试验合成的阿哌沙班-烟酸一水合物共晶物进行了表征。对共晶稳定性、溶解性和引湿性进行了研究,相较于阿哌沙班,共晶在不同pH介质中的溶解度提高了2~3倍,理化成药性良好。 Apixaban-nicotinic acid monohydrate co-crystal,which was composed of a molecule apixaban,a molecule nicotinic acid and a molecule water.Apixaban and nicotinic acid were respectively dissolved in trifluoroethanol containing 0.5% water at 25 ℃ and stirred 3 h.And then added ethyl acetate and stirred 2 h at same temperature to precipitate the co-crystal.The co-crystal was obtained through filtering and drying.The structure of co-crystal was characterized by ^(1)H-NMR,elements analysis,water content analysis,X-ray power diffraction(XRPD),differential scanning calorimetry(DSC),thermal gravimetric analysis(TGA) and infrared(IR) spectrum,respectively.The stability,solubility and hygroscopicity of the co-crystal were also assessed.The results showed that the solubility of co-crystal in various pH solution were increased to two to three times as compared with apixaban.The physical and chemical properties of co-crystal are very good.■。
作者 黄小光 傅红燕 崔姣 HUANG Xiao-guang;FU Hong-yan;CUI Jiao(Department of Drug Research and Development,Guangzhou Baiyunshan Tianxin Pharmaceutical Co.,Ltd.,Guangzhou 510300,China)
出处 《中国药物化学杂志》 CAS CSCD 2021年第12期988-993,共6页 Chinese Journal of Medicinal Chemistry
关键词 阿哌沙班 共晶 制备 表征 性质 apixaban co-crystal preparation characterization properties
  • 相关文献

参考文献5

二级参考文献128

  • 1Walsh R B, Padgett C W, Metrangolo P, et al. Crystal Growth & Design, 2001, 1(2) : 165-175.
  • 2Oswald I, Motherwell W, Parsons S. Acta Crystallographica Section E: Structure Reports Online, 2004, 60 ( 11 ) : 1967- 1969.
  • 3Almarsson Z M. Chemical Communications, 2004, 1889-1896.
  • 4Caira M. Mol. Pharma. , 2007, 4:310-316.
  • 5Aaker~y C. Acta Crystaltographica Section B: Structural Science, 1997, 53 (4): 569-586.
  • 6Blagden N, De Matas M, Gavan P, et al. Advanced Drug Delivery Reviews, 2007, 59(7): 617-630.
  • 7Huang C, Leiserow L, Schmidt G. J. Chem. Soc. , 1973, 2: 503 -508.
  • 8Remenar J, Morissette S, Peterson M, et al. Journal of the American Chemical Society, 2003, 125 (28) : 8456-8457.
  • 9Childs S, Chyall L, Dunlap J, et al. Journal of the American Chemical Society, 2004, 126(41): 13335-13342.
  • 10Vishweshwar P, Mcmahon J, Peterson M, et al. Chemical Communications, 2005, 4601-4603.

共引文献93

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部